A randomised double-blind placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at risk Mental States: The NAYAB study
出版年份 2023 全文链接
标题
A randomised double-blind placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at risk Mental States: The NAYAB study
作者
关键词
-
出版物
BRAIN BEHAVIOR AND IMMUNITY
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-11-03
DOI
10.1016/j.bbi.2023.10.025
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Serum immune markers and transition to psychosis in individuals at clinical high risk
- (2023) Valeria Mondelli et al. BRAIN BEHAVIOR AND IMMUNITY
- Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial
- (2021) Maria Antonietta Nettis et al. NEUROPSYCHOPHARMACOLOGY
- Doxycycline exposure during adolescence and future risk of non-affective psychosis and bipolar disorder: a total population cohort study
- (2021) Fredrik Upmark et al. Translational Psychiatry
- Meta-analysis of the Glial Marker TSPO in Psychosis Revisited: Reconciling Inconclusive Findings of Patient–Control Differences
- (2020) Pontus Plavén-Sigray et al. BIOLOGICAL PSYCHIATRY
- Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning
- (2019) Carl M. Sellgren et al. NATURE NEUROSCIENCE
- Meta-analysis of cytokine and C-reactive protein levels in high-risk psychosis
- (2019) Sora Park et al. SCHIZOPHRENIA RESEARCH
- Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial
- (2019) Maximus Berger et al. Frontiers in Psychiatry
- The NEURAPRO biomarker analysis: long-chain omega-3 fatty acids improve 6-month and 12-month outcomes in youth at ultra-high risk for psychosis
- (2019) G Paul Amminger et al. BIOLOGICAL PSYCHIATRY
- Efficacy of omega-3 PUFAs in depression: A meta-analysis
- (2019) Yuhua Liao et al. Translational Psychiatry
- Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis
- (2019) Ayedh Alqarni et al. SCHIZOPHRENIA RESEARCH
- Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis
- (2018) Cathy Davies et al. World Psychiatry
- A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidone
- (2018) Delbert G. Robinson et al. SCHIZOPHRENIA RESEARCH
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis
- (2018) Toby Pillinger et al. SCHIZOPHRENIA BULLETIN
- The effect of minocycline on symptoms in schizophrenia: Results from a randomized controlled trial
- (2018) Mark Weiser et al. SCHIZOPHRENIA RESEARCH
- Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial
- (2017) Muhammad I Husain et al. JOURNAL OF PSYCHOPHARMACOLOGY
- 23. Omega-3 Fatty Acid Versus Placebo in a Clinical High-Risk Sample From the North American Prodrome Longitudinal Studies (NAPLS) Consortium
- (2017) Kristin Cadenhead et al. SCHIZOPHRENIA BULLETIN
- The Clinical High-Risk State for Psychosis (CHR-P), Version II
- (2017) Paolo Fusar-Poli SCHIZOPHRENIA BULLETIN
- A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol
- (2017) Inti Qurashi et al. Trials
- Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders
- (2017) Patrick D. McGorry et al. JAMA Psychiatry
- Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression
- (2016) Brian Hallahan et al. BRITISH JOURNAL OF PSYCHIATRY
- Omega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methods
- (2015) Tomasz Pawełczyk et al. BMC Psychiatry
- A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia
- (2013) H Bentsen et al. Translational Psychiatry
- Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
- (2012) Imran B Chaudhry et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Validity of the 16-Item Version of the Prodromal Questionnaire (PQ-16) to Screen for Ultra High Risk of Developing Psychosis in the General Help-Seeking Population
- (2012) H. K. Ising et al. SCHIZOPHRENIA BULLETIN
- Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders
- (2010) G. Paul Amminger et al. ARCHIVES OF GENERAL PSYCHIATRY
- Prediction of Psychosis in Youth at High Clinical Risk
- (2008) Tyrone D. Cannon et al. ARCHIVES OF GENERAL PSYCHIATRY
- Microglia Activation in Recent-Onset Schizophrenia: A Quantitative (R)-[11C]PK11195 Positron Emission Tomography Study
- (2008) Bart N. van Berckel et al. BIOLOGICAL PSYCHIATRY
- Minocycline as Adjunctive Therapy for Schizophrenia
- (2008) Tsuyoshi Miyaoka et al. CLINICAL NEUROPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now